ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Entero Therapeutics Inc

Entero Therapeutics Inc (ENTO)

0.352
-0.0141
(-3.85%)
Closed September 17 4:00PM
0.352
0.00
( 0.00% )
Pre Market: 4:36AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.352
Bid
0.3362
Ask
0.4763
Volume
-
0.00 Day's Range 0.00
0.185 52 Week Range 3.16
Previous Close
0.352
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
649,059
Financial Volume
-
VWAP
-

ENTO Latest News

Entero Therapeutics Signs Letter of Intent to License and Commercialize Remote Patient and Machine Vision Clinical Trial Management Platform from Data Vault Holdings

BOCA RATON, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...

Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q

BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...

Entero Therapeutics’ Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program

BOCA RATON, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...

Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Intestinal Damage in Celiac Disease

New VCIEL scale provides a more sensitive and quantitative metric of small intestinal health for monitoring Celiac Disease severity and treatment efficacy Special editorial highlights the...

Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention

BOCA RATON, Fla., May 22, 2024 (GLOBE NEWSWIRE) --  Entero Therapeutics, Inc. (formerly First Wave BioPharma, Inc.) (Nasdaq: ENTO) (“Entero” or the “Company”), a late clinical-stage...

Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference

BOCA RATON, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing in...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.063-15.18072289160.4150.450.281496030.35642666CS
4-0.004-1.123595505620.3560.460.25012273170.40441301CS
12-1.408-801.761.840.1856490590.37948068CS
26-2.608-88.10810810812.963.160.1854545050.41571485CS
52-2.608-88.10810810812.963.160.1854545050.41571485CS
156-2.608-88.10810810812.963.160.1854545050.41571485CS
260-2.608-88.10810810812.963.160.1854545050.41571485CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PRTGPortage Biotech Inc
$ 16.22
(258.06%)
2.08M
OMEXOdyssey Marine Exploration Inc
$ 0.9057
(82.49%)
10.7M
AGFYAgrify Corporation
$ 0.36
(42.86%)
345
LUNRIntuitive Machines Inc
$ 7.575
(40.28%)
3.89M
WBUYWeBuy Global Ltd
$ 0.1535
(32.33%)
4.65M
GLMDGalmed Pharmaceuticals Ltd
$ 9.99
(-33.84%)
153.67k
WHLRWheeler Real Estate Investment Trust Inc
$ 7.28
(-21.72%)
69.5k
SMSISmith Micro Software Inc
$ 0.895
(-21.49%)
458.55k
RAYAErayak Power Solution Group Inc
$ 0.55
(-18.52%)
1
HCTIHealthcare Triangle Inc
$ 0.372
(-18.15%)
58.78k
OMEXOdyssey Marine Exploration Inc
$ 0.9083
(83.01%)
10.7M
WBUYWeBuy Global Ltd
$ 0.1541
(32.84%)
4.66M
LUNRIntuitive Machines Inc
$ 7.57
(40.19%)
3.89M
PRTGPortage Biotech Inc
$ 16.10
(255.41%)
2.09M
VVPRVivoPower International PLC
$ 1.57
(25.60%)
1.57M

Your Recent History

Delayed Upgrade Clock